echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimer's dementia: Longitudinal changes in Alzheimer's disease biomarkers differ between cognitively normal blacks and whites

    Alzheimer's dementia: Longitudinal changes in Alzheimer's disease biomarkers differ between cognitively normal blacks and whites

    • Last Update: 2022-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Alzheimer's disease (AD) is an irreversible neurodegenerative disease that affects approximately 6 million Americans, and the number of cases is expected to more than double by 2050
    .


    Solutions to this public crisis require prevention and/or treatment options that are effective for all, including underrepresented groups


    Alzheimer's disease (AD) is an irreversible neurodegenerative disease that affects approximately 6 million Americans, and the number of cases is expected to more than double by 2050


    Almost all of these important findings were based on predominantly white populations, and racial differences in AD biomarkers have rarely been studied


    Alzheimer's disease (AD) biomarkers including cerebrospinal fluid (CSF) markers, amyloid uptake by positron emission tomography (PET), structural changes and cognition by magnetic resonance imaging (MRI), and their current longitudinal changes No comparisons have been made between blacks and whites


    Chengjie Xiong et al.


    A total of 179 blacks and 1180 whites in the study were cognitively normal at baseline and had longitudinal data from at least one biomarker pattern, and the team analyzed their annual rate of change
    .

    A total of 179 blacks and 1180 whites in the study were cognitively normal at baseline and had longitudinal data from at least one biomarker pattern, and the team analyzed their annual rate of change
    .


    Differences in estimated annual rates of change in biomarkers between blacks and whites

    Differences in estimated annual rates of change in biomarkers between blacks and whites

    Blacks had slower decline in CSF β amyloid (Aβ)42/Aβ40 than whites (P = 0.
    0390) and slower amyloid (PET) accumulation (P = 0.
    0157)
    .

    Blacks had slower decline in CSF β amyloid (Aβ)42/Aβ40 than whites (P = 0.
    0390) and slower amyloid (PET) accumulation (P = 0.
    0157)
    .


    Blacks had slower decline in CSF β amyloid (Aβ)42/Aβ40 than whites (P = 0.


    Model Fit Plot of Longitudinal Trajectories of Biomarkers

    Model Fit Plot of Longitudinal Trajectories of Biomarkers

    CSF Aβ42 varied in opposite directions over time between blacks and whites (P = 0.
    0039)
    .


    The annual increase in total tau and phosphorylated tau181 in black CSF was approximately half that in whites


    CSF A CSF A β42 varied in opposite directions over time between blacks and whites (P = 0.


    In conclusion, the team observed longitudinal ethnic differences in amyloid biomarkers


    original source

    Xiong, Chengjie et al.


    Xiong, Chengjie et al.
    “Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults.
    ”  Alzheimer's & dementia: the journal of the Alzheimer's Association , 10.
    1002/alz.
    12608.
    25 Feb.
    2022, doi:10.
    1002/alz.
    12608 Xiong , Chengjie et al.
    "Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults.
    "  Alzheimer's & dementia : the journal of the Alzheimer's Association commented here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.